Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
---|
07/18/2002 | US20020094983 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
07/18/2002 | US20020094453 Metal coordination compound, luminescence device and display apparatus |
07/18/2002 | DE10102053A1 Piperazinylcarbonyl-quinoline and piperazinylcarbonyl-isoquinoline derivatives useful for treatment of e.g. schizophrenia, psychoses, depression, Parkinson's disease and Alzheimer's disease |
07/18/2002 | CA2434205A1 1,1-disubstituted cyclic inhibitors of matrix metalloprotease and tnf-.alpha. |
07/18/2002 | CA2434152A1 Therapeutic heterocyclic compounds |
07/18/2002 | CA2434015A1 Therapeutic chroman compounds |
07/18/2002 | CA2433950A1 Therapeutic chromone compounds |
07/17/2002 | EP1222920A2 Mitochondria protecting agents for treating mitochondria associated diseases |
07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
07/17/2002 | CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof |
07/17/2002 | CN1087725C Enhancement of the effect of drugs by deuteration |
07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
07/16/2002 | US6420424 CCR-3 receptor antagonists |
07/16/2002 | US6420423 Pesticides |
07/16/2002 | US6420387 Antitumor |
07/16/2002 | US6420363 Mono- or polyenic carboxylic acid derivatives |
07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
07/11/2002 | WO2002036734A3 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
07/11/2002 | WO2001024785A3 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
07/11/2002 | US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance |
07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
07/10/2002 | EP1221434A1 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element |
07/10/2002 | CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
07/10/2002 | CN1357541A Phosphatidase A2 inhibitor and its prepn process and use |
07/10/2002 | CN1087294C Novel compounds |
07/10/2002 | CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
07/09/2002 | US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
07/09/2002 | US6417367 Methods of making quinoline amides |
07/09/2002 | US6417366 Chemical intermediate for macrolactone antibiotic |
07/09/2002 | CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them |
07/04/2002 | WO2002051830A1 Carboxamides for use as telomerase inhibitors |
07/04/2002 | WO2002036556A3 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
07/04/2002 | WO2001098275A3 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
07/04/2002 | US20020086887 N-Acylsulfonamide apoptosis promoters |
07/04/2002 | DE10065043A1 Carbonsäureamide, diese Verbindungen enthaltene Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicines, these compounds contained, their use and production |
07/03/2002 | EP1219607A1 Integrase inhibitors containing aromatic heterocycle derivatives |
07/03/2002 | EP1218345A1 Method of making metal 8-quinolinolato complexes |
07/03/2002 | EP1218336A2 Melanin concentrating hormone antagonist |
07/03/2002 | EP0860433B1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same |
07/03/2002 | CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
07/03/2002 | CN1356990A Bicyclic heterocycles, medicaments contg. these compounds, their use and methods for prodn. thereof |
07/03/2002 | CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands |
07/03/2002 | CN1356977A Glucagon antagonists/inverse agonists |
07/03/2002 | CN1356038A Fungiciding mixture |
07/02/2002 | US6414012 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof |
07/02/2002 | US6413985 Selective antagonists for the strychnine insensitive glycine binding site associated with the nmda receptor complex. |
07/02/2002 | US6413969 Gatifloxacin pentahydrate |
07/02/2002 | US6413956 Substituted 4-oxo-quinoline-3-carboxamides |
07/02/2002 | CA2104839C Arylazo chromoionophores |
07/02/2002 | CA2065846C Quinolone carboxylic acid derivatives |
06/27/2002 | WO2002050081A2 Antimicrobial agents |
06/27/2002 | WO2002050041A1 Dihydroindole and tetrahydroquinoline derivatives |
06/27/2002 | WO2002050040A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
06/27/2002 | WO2002049993A2 High affinity small molecule c5a receptor modulators |
06/27/2002 | WO2002049632A1 Inhibitors against the production and release of inflammatory cytokines |
06/27/2002 | WO2002024652B1 Compounds and methods for diagnosing and treating amyloid-related conditions |
06/27/2002 | WO2001018171A3 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
06/27/2002 | US20020082424 Alkylating an aryl halide with 1,3-dichloropropene and n-tetrabutylammonium iodide catalyst for forming vinyl chloride compound which is subjected to cyclization using tribuytyl tin hydride, catalyst and toluene as the solvent |
06/27/2002 | US20020082283 Increasing the function of the N-methylaspartic acid (NMDA) receptor without the inherent side-effects associated with modulation of the glutamate binding site |
06/27/2002 | US20020082276 Quinoline derivatives as anti-inflammatory agents |
06/27/2002 | US20020082274 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
06/27/2002 | US20020082262 Regulate the cellular transport proteins P- glycoprotein and MRP1 , which are the proteins believed to be responsible for multidrug resistance in cancer patients |
06/27/2002 | US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins |
06/26/2002 | EP1216980A1 Carboxylic acid derivatives and drugs containing the same |
06/26/2002 | CN1355697A IL-8 receptor antagonists |
06/26/2002 | CN1086702C 4-hydroxy-piperidine-derivatives |
06/26/2002 | CN1086569C Dehydration plant |
06/25/2002 | US6410783 Salt formation with dicamba; dehydration |
06/25/2002 | US6410563 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
06/25/2002 | US6410561 Analgesics |
06/25/2002 | US6410558 Using indole or quinoline compound |
06/25/2002 | US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists |
06/25/2002 | US6410521 Nutritional supplements for stimulating bone growth |
06/25/2002 | US6410480 Plant safening agents and growth regulators for controlling weeds and grasses; post/preemergence herbicides |
06/25/2002 | US6409812 AZO compounds and process for producing the same |
06/20/2002 | WO2002048113A1 Cyclization process step in the making of quinolones and naphthyridines |
06/20/2002 | WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
06/20/2002 | WO2002047687A1 Urotensin-ii receptor antagonists |
06/20/2002 | WO2002047456A2 Urotensin-ii receptor antagonists |
06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
06/20/2002 | WO2002004422A3 Heterocycle carboxamides as antiviral agents |
06/20/2002 | US20020077481 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates |
06/20/2002 | US20020077455 Protease inhibitors |
06/20/2002 | US20020077338 HIV protease inhibitors |
06/20/2002 | US20020077335 For therapy of asthma, chronic obstructive pulmonary disease, airway hyperreactivity, skin disorders and itch (for example, atopic dermatitis and cutaneous wheal and flare), neurogenic inflammation and Parkinson's disease, psychosis |
06/19/2002 | EP1214292A1 Tyrosine derivatives |
06/19/2002 | CN1354746A 6.7-disubstituted-5,8-quinolinedione derivatives as antifungal agent |
06/18/2002 | US6407248 α-unsaturated amines, their production and use |
06/18/2002 | US6407096 Benzene fused heterocyclic derivatives having thromboxane A2 receptor antagonistic activity and prostaglandin I2 Agonistic activity and application thereof |
06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
06/13/2002 | WO2002046173A1 Fused heteroaromatic glucokinase activators |
06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
06/13/2002 | WO2002046163A2 Quinoline derivatives and their use as anti-epileptics |
06/13/2002 | WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
06/13/2002 | WO2002045703A2 Mixtures or organic compounds for the treatmentof airway diseases |